Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care

Scand J Rheumatol. 2018 Sep;47(5):418-421. doi: 10.1080/03009742.2017.1376110. Epub 2018 Jan 9.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antibodies / blood
  • Antibodies, Monoclonal / blood*
  • Antibodies, Monoclonal / immunology
  • Arthritis / blood
  • Arthritis / drug therapy*
  • Denmark
  • Female
  • Follow-Up Studies
  • Humans
  • Infliximab / administration & dosage*
  • Infliximab / blood
  • Male
  • Middle Aged

Substances

  • Antibodies
  • Antibodies, Monoclonal
  • CT-P13
  • Infliximab